Stock Taper
Translational Development Acquisition Corp., established in 2022 and headquartered in New York, New York, currently possesses no significant business operations. Its primary objective is to finalize a strategic business combination, which could involve a merger, share exchange, asset acquisition, or reorganization, with one or more other entities.

Overall rating: A+
| PEER | PRICE | |
|---|---|---|
HVII | $10.30 | COMPARE |
PLMK | $10.43 | COMPARE |
VNME | $10.07 | COMPARE |
RANG | $10.40 | COMPARE |
IPOD | $10.19 | COMPARE |
QETA | $11.20 | COMPARE |
APLM | $17.02 | COMPARE |
LPAAW | $0.25 | COMPARE |